Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Identification of Rare Genetic Disorders in Kidney Transplantation Recipients with Un-Diagnosed Nephropathy through NGS Approach
G. Castellano, M. Giliberti, P. Pontrelli, M. Gigante, S. Diella, M. Accetturo, E. Stea, A. Mitrotti, L. Gesualdo
Emergency and Organ Transplantation, University of Bari, Bari, Italy
*Purpose: About 10% of end stage renal disease (ESRD) patients have no diagnosis of the primary kidney disease. Patients with unknown renal pathology can access…
2019 American Transplant Congress
In Depth Look at Acute Rejections in LCP-Tacrolimus (LCPT; Envarsus XR) and Immediate-Release Tacrolimus (IR-Tac)-Treated De Novo Kidney Transplant Recipients
A. Condon¹, M. Mujtaba², S. J. Patel³, D. R. Stevens³, U. Meier-Kriesche³
¹University of New Mexico Hospitals, Albuquerque, NM, ²University of Texas Medical Branch, Galveston, TX, ³Veloxis Pharmaceuticals Inc., Cary, NC
*Purpose: A prospective, randomized controlled trial has shown comparable rates of biopsy-proven rejection (BPAR) between LCPT and IR-Tac treated renal transplant recipients. This analysis aims…
2019 American Transplant Congress
Impact of Prolonged Venous Thromboembolism Prophylaxis on 30-Day Hemostatic Outcomes Following Kidney Transplantation in Patients with Hypercoagulable Risk Factors
V. Behbahani, A. Santeusanio, S. Ames, R. Shapiro
Mount Sinai Hospital, New York, NY
*Purpose: A number of hypercoagulable states have been identified through laboratory testing that place patients at greater risk for thrombosis; however, the appropriate management of…
2019 American Transplant Congress
Good Outcomes of Octagenerian Kidney-Transplant Recipients: A Single-Center Experience
S. Sultan, M. Aull, M. Lubetzky, A. Watkins, S. Kapur
New York Presbyterian / Weill Cornell, New York, NY
*Purpose: Given the aging population of patients with end-stage renal disease, the transplant community is increasingly confronted with the challenge of evaluating elderly patients for…
2019 American Transplant Congress
En Bloc Kidney Transplant from Infant Donors Less Than 5kg into Adult Recipients
Z. Wang, Q. Xia, M. Wang, H. Li, J. Liu, J. Liu, J. Liu
Urology, Union hospital, Wuhan, China
*Purpose: To explore the feasibility of en bloc kidney transplantation from infant donors less than 5kg into adult recipients.*Methods: A retrospective analysis was conducted of…
2019 American Transplant Congress
Panniculectomy at the Time of Living Donor Renal Transplantation: An Eight Year Experience
L. M. Ngaage¹, A. Elegbede², K. K. Tasidina¹, S. Gebran³, E. Rada¹, A. J. Nam³, J. R. Scalea⁴, S. Niederhaus⁴, D. Singh¹, J. S. Bromberg⁴, S. T. Bartlett⁴, Y. M. Rasko¹
¹Department of Plastic Surgery, University of Maryland Medical Center, Baltimore, MD, ²Department of Plastic & Reconstructive Surgery, Johns Hopkins Hospital / University of Maryland Medical Center, Baltimore, MD, ³Division of Plastic & Reconstructive Surgery, R Adams Cowley Shock Trauma Center, Baltimore, MD, ⁴Department of Transplant Surgery, University of Maryland Medical Center, Baltimore, MD
*Purpose: Removal of the pannus, or panniculectomy, can be performed as a prophylactic procedure preceding renal transplantation to enable obese patients to meet criteria for…
2019 American Transplant Congress
A Clinical Analysis for Low-Dose Immunoglobulin United with Plasmapheresis in High Sensitization Renal Transplantation Recipients
L. Xu¹, J. Zhang²
¹Chinese PLA General Hospital Eighth Medical Centre, Beijing, China, ²Nursing Department, Chinese PLA General Hospital, Beijing, China
*Purpose: To analyze the role of low-dose intravenous immunoglobulin (IVIG) united with plasmapheresis in high sensitization renal transplantation recipients.*Methods: Four patients with high levels of…
2019 American Transplant Congress
Variations in Recipient and Donor Clinical Characteristics between Kidney Transplant Centers
W. T. McKinney¹, M. Bruin², S. Chu², D. Schladt³, J. Snyder³, A. Matas⁴, B. Kasiske⁵, A. K. Israni³
¹Nephrology, Hennepin Healthcare Research Institute, Minneapolis, MN, ²College of Design, University of Minnesota, St. Paul, MN, ³Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN, ⁴Department of Surgery, University of Minnesota, Minneapolis, MN, ⁵Department of Medicine, Hennepin Healthcare, Minneapolis, MN
*Purpose: When a patient can choose at which kidney transplant program to establish care, prior knowledge of program acceptance practices (of candidates and donors) can…
2019 American Transplant Congress
Impact of Everolimus Therapy on HIV Persistence and Gene Expression in Transplant Patients
A. Zarinsefat¹, C. Schreiner¹, C. Cameron², S. Chu¹, M. P. Busch¹, T. Liegler¹, S. G. Deeks¹, T. J. Henrich¹, P. G. Stock¹
¹UC San Francisco, San Francisco, CA, ²Case Western Reserve University, Cleveland, OH
*Purpose: mTOR is a key regulatory kinase that controls cell-cycle progression. mTOR inhibitors have been shown to reduce expression of CCR5 and promote viral transcriptional…
2019 American Transplant Congress
Impact of an mHealth, Electronic Pillbox Intervention on Tacrolimus Variability in Kidney Transplantation: Results of a Prospective Randomized Clinical Trial
J. W. McGillicuddy, L. Sox, J. Chandler, F. Treiber, D. Taber
Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor and leading cause of late allograft loss in kidney transplant (KTX) recipients. Tacrolimus trough concentration variability,…